Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrzej Szczepaniak
Institution:
Poznan University of Medical Sciences
Observed institution:
Poznan University of Medical Sciences
ORCID:
0000-0002-1732-8964
Observed ORCID:
0000-0002-1732-8964
OpenAlex ID:
A5071060990
Structural basis of methotrexate and pemetrexed action on serine hydroxymethyltransferases revealed using plant models
2019
·
Milosz Ruszkowski
, Bartosz Sekula
, et al.
·
Scientific Reports
·
25
PDF
The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a “real‐world” study: Polish Myeloma Group experience
2018
·
Grzegorz Charlinski
, Norbert Grzasko
, et al.
·
European Journal Of Haematology
·
19
Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion
2013
·
Maciej Kaźmierczak
, Renata Kroll-Balcerzak
, et al.
·
Medical Oncology
·
19
PDF
Spontaneous hematological remission of acute myeloid leukemia
2014
·
Maciej Kaźmierczak
, Andrzej Szczepaniak
, et al.
·
Współczesna Onkologia
·
11
PDF
Primary and Secondary Central Nervous System Involvement in Acute Myeloid Leukemia
2019
·
Elżbieta Patkowska
, Andrzej Szczepaniak
, et al.
·
Journal of Leukemia
·
10
Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm
2019
·
Andrzej Szczepaniak
, Marcin Machnicki
, et al.
·
International Journal of Hematology
·
8
Hodgkin lymphoma transformation of chronic lymphocytic leukemia—A real life data from the Polish Lymphoma Research Group
2019
·
Joanna Drozd‐Sokołowska
, Jan Maciej Zaucha
, et al.
·
Hematological Oncology
·
7
The prognostic significance of bone marrow histological evaluation in patients with multiple myeloma
2021
·
Andrzej Szczepaniak
, Macie Kaźmierczak
, et al.
·
Acta Haematologica Polonica
·
4
PDF
CD34+/CD3+ cells ratio in the peripheral blood stem cells product and graft-versus-host disease: Is there still room for improvement?
2026
·
Ewa Bembnista
, Paula Matuszak
, et al.
·
Transplant Immunology
·
1
Disease presentation and immunophenotype characteristics in 257 patients with blastic plasmacytoid dendritic cell neoplasm: A pethema/PALG study
2025
·
Beatriz Martín Herreros
, Irene Navarro Vicente
, et al.
·
Blood
·
1
A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized study
2025
·
Agnieszka Wierzbowska
, Anna Czyz
, et al.
·
Blood
·
1
Prospective assessment of measurable residual disease kinetics in intensively treated patients with Acute Myeloid Leukemia (AML) - results of the PALG-AML1/2016 study
2025
·
Agnieszka Wierzbowska
, Agnieszka Pluta
, et al.
·
Blood
·
1
PDF
Clinical Features and Outcomes in 228 Patients Diagnosed with Blastic Plasmocytoid Dendritic Cell Neoplasm: A Pethema/PALG Study
2024
·
Irene Navarro Vicente
, Antonio Solana-Altabella
, et al.
·
Blood
·
1
Managing post-transplant relapse in FLT3-mutated AML with gilteritinib
2024
·
Zuzanna M. Rzetelska
, Andrzej Szczepaniak
, et al.
·
Acta Haematologica Polonica
·
1
PDF
A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study
2023
·
Agnieszka Wierzbowska
, Agnieszka Pluta
, et al.
·
Blood
·
1
PDF
A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and De Novo APL - a Case-Match Retrospective Analysis of Polish Adult Leukemia Group (PALG)
2022
·
Agnieszka Pluta
, Marta Anna Sobas
, et al.
·
Blood
·
1
A Polish Acute Leukemia Group Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016)
2020
·
Agnieszka Wierzbowska
, Agnieszka Pluta
, et al.
·
Blood
·
1
A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and De Novo APL—A Case-Matched Retrospective Analysis of the Polish Adult Leukemia Group (PALG)
2026
·
Agnieszka Pluta
, Damian Mikulski
, et al.
·
Cancers
POSTER: AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026
·
Zuzanna Nowicka-Kaszkowiak
, Agnieszka Pluta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026
·
Zuzanna Nowicka-Kaszkowiak
, Agnieszka Pluta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Introducing CAR T-cell therapy into clinical practice for mantle cell lymphoma: real-world experience from Poland
2026
·
Anna Łojko-Dankowska
, Dominik Dytfeld
, et al.
·
Archives of Medical Science
PDF
Ophthalmic complications associated with chimeric antigen receptor T-cell therapy: a review of current evidence
2026
·
Joanna Mamczur-Załęcka
, Lidia Gil
, et al.
·
Współczesna Onkologia
Resistant thrombotic thrombocytopenic purpura successfully treated with caplacizumab preceding acute myeloid leukemia
2025
·
Łukasz Mazurkiewicz
, Maria M. Joks
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
PDF
Gilterytynib w leczeniu pacjentki ze wznową ostrej białaczki szpikowej z mutacją FLT3-ITD po transplantacji allogenicznych komórek krwiotwórczych
2024
·
Zuzanna Magdalena Rzetelska
, Andrzej Szczepaniak
, et al.
·
Hematologia — Edukacja
PDF
The Experience of Commercially Available CPX-351 Use As First-Line Treatment for Patients with Acute Myeloid Leukemia - a Report of Polish Adult Leukemia Group (PALG)
2024
·
Agnieszka Pluta
, Olga Racinska
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
40
Citation count:
112
H-index:
7
I10-index:
5
Year
Topic
Type